The prevalence of irritable bowel syndrome‐type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity
Authors:
- 25 April 2016
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 44 (2) , 181-188
Abstract
Summary: Background: A large proportion (25–46%) of adults with inflammatory bowel disease in remission has symptoms of irritable bowel syndrome (IBS), which are thought to reflect ongoing inflammation. Data on paediatric inflammatory bowel disease patients are lacking.Aim: To investigate (i) the prevalence of IBS‐type symptoms in paediatric inflammatory bowel disease patients in remission and (ii) the relationship of IBS‐type symptoms with biochemical markers of disease activity.Methods: This cross‐sectional study included all patients (P = 0.12; CRP: IBS+ median 1.4 mg/L, IBS− 1.1 mg/L, P = 0.63).Conclusions: The prevalence of IBS‐type symptoms in children with inflammatory bowel disease is highly dependent on the definition of remission. Nonetheless, the prevalence is much lower than that previously reported in studies in adult inflammatory bowel disease patients. IBS‐type symptoms appear to be unrelated to gastrointestinal inflammation.Keywords
This publication has 24 references indexed in Scilit:
- Letter: the role of sub-clinical inflammation and TRPV1 in the development of IBS-like symptoms in ulcerative colitis in remissionAlimentary Pharmacology & Therapeutics, 2013
- Characterization of IBS‐like symptoms in patients with ulcerative colitis in clinical remissionNeurogastroenterology & Motility, 2013
- Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub‐clinical inflammation and the impact on clinical assessment of disease activityAlimentary Pharmacology & Therapeutics, 2013
- The Overlap of Functional Abdominal Pain in Pediatric Crohn’s DiseaseInflammatory Bowel Diseases, 2013
- Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in RemissionGastroenterology Research and Practice, 2013
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studiesInflammatory Bowel Diseases, 2012
- Pediatric modification of the Montreal classification for inflammatory bowel diseaseInflammatory Bowel Diseases, 2011
- Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2010
- The Functional Gastrointestinal Disorders and the Rome III ProcessGastroenterology, 2006